Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Ricciardi

P1.04-28 Baseline Markers of Inflammation and Outcome With Nivolumab in Pretreated Non Small Cell Lung Cancers: A Retrospective Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Numerical Strategy for Dynamic Simulation of Impacts on SFR Fuel Pins and Experimental Validation

Nuclear Engineering and Design
Materials ScienceRiskMechanical EngineeringWaste ManagementNuclearNuclear EnergyHigh Energy PhysicsEngineeringReliabilitySafetyDisposalQuality
2018English

Related publications

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Real-World Effectiveness and Safety of Nivolumab in Patients With Non-Small Cell Lung Cancer: A Multicenter Retrospective Observational Study in Japan

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study

Oncology Letters
Cancer ResearchOncology
2010English

P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit From Nivolumab in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2015English

P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.04-33 Retrospective Descriptive Analysis of Metformin With Atezolizumab in Advanced Non-Small Cell Lung Cancer in the OAK Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinical Factors Associated With Early Progression and Grade 3–4 Toxicity in Patients With Advanced Non-Small-Cell Lung Cancers Treated With Nivolumab

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy